The United States is falling dangerously behind in medical research as other countries make tremendous progress. Mike Papantonio & Farron Cousins discuss more.
Transcript:
*This transcript was generated by a third-party transcription software company, so please excuse any typos.
Mike Papantonio: The United States is falling dangerously behind in medical research as other companies make tremendous progress. Farron, this story about the Cub, about Cuba drugs, Cuban drugs that really are making a difference in Alzheimer’s disease. Now we compare that to what happened with GenTech and what happened with Biogen, GenTech and Biogen lied to the American public for a decade. They said, we have this great Alzheimer’s drug. The, even, even the clinicals were phonied up. But we know the Cubans, the Cuban drug really does work. I mean, there’s, the clinicals are, are first of all, they’re honest, nothing phonied up and it’s working.
Farron Cousins: Right.
Mike Papantonio: Give me your take on it.
Farron Cousins: The, Cuba is now in phase four.
Mike Papantonio: Yes.
Farron Cousins: Of their drug trials for this Alzheimer’s and Parkinson’s drug, because it’s showing that, hey, it’s stopping, it is stopping brain deterioration and helping people actually improve their cognitive functions.
Mike Papantonio: Yeah.
Farron Cousins: That is amazing. They’re almost, I mean, I don’t want to give too much hope here, but it seems like they’re almost reversing these, these conditions.
Mike Papantonio: If you read the, if you read the articles, you, you, you certainly looks like that.
Farron Cousins: Yeah. And then we, as you said, contrast this to the US, which by the way, both of these stories came out within about 48 hours of each other.
Mike Papantonio: Mm-hmm.
Farron Cousins: And nobody connected them.
Mike Papantonio: No.
Farron Cousins: But the US, 20 years, our drug companies that we are funding through the National Institute of Health using taxpayer dollars.
Mike Papantonio: Mm-hmm.
Farron Cousins: It’s so, the phoning up was so bad, they weren’t just lying about the results, they were Photoshopping their own images of people’s brains.
Mike Papantonio: Yes.
Farron Cousins: To show, oh, look, it got better.
Mike Papantonio: Yes.
Farron Cousins: And then they finally looked and said, wait a minute, you just took a picture of a healthy brain and cut out that part and glued it on top.
Mike Papantonio: Okay. There’s a reason for all this. Okay. And there, we have a 99% failure rate with American, 99%, with American companies that are saying, we’re solving this problem. First of all, they started off with a lie. That, that’s where this all begins.
Farron Cousins: Yeah.
Mike Papantonio: The big lie started off with phonied up research that was coming that said, look, if we can deal with the amyloid problem and the plaque problem, if we can reduce the amyloid problem in the brain and the plaque problem in the brain, we’re gonna cure it. They found out, no, that’s not even, it’s not even accurate. They were said, we, we have a drug because we have reduced plaques and we have reduced the amyloid problem, but it had nothing to do in the long run with Alzheimer’s.
Farron Cousins: Right. So they developed these drugs that attacked these issues that were not the issues.
Mike Papantonio: Yeah.
Farron Cousins: And honest to God, the difference here, because it’s not just Cuba, who also, by the way, has a lung cancer vaccine that we’re in the US not allowed to take. So they’ve got this, they’ve got the Parkinson’s treatment, the Alzheimer’s. South Korea has become a leader in medical develop. China, China has taken over.
Mike Papantonio: Mm-hmm.
Farron Cousins: It’s because we are profit driven here in the United States. We let big profits, so instead of tackling the real diseases, what are our drug companies doing? We’ll look at the ads on TV. Are you moving your leg a little too much while you sleep? Here’s $500 a month for this drug. It’ll stop your leg movement. Are your eyes a little too scratchy every now and then?
Mike Papantonio: Mm-hmm.
Farron Cousins: Those are the problems we’re tackling while the rest of the world.
Mike Papantonio: It’s low, it’s called low, corporate low hanging fruit.
Farron Cousins: Yeah.
Mike Papantonio: Okay. And, and here’s, here’s one big difference. When, the best article that I saw that analyzed this, they said, look, there’s a research gap in America that there’s not in some of these other companies, in other countries like Cuba, because the, the, the research is driven by government. Government is hands on, on that research. Academic institutions are hands on with that research. And, and then they tie up the idea that if we compare our kind of what, what you, what you would call is the stem system of education, where they, they, they found out now we don’t, we don’t, we don’t, teach calculus. We don’t teach the kind of advanced biology that people need to have in school. We’ve cut back all of our hard, hard sciences for the most part in public schools. And these, the, the list of comparisons between why we’re, we are where we are in the United States with corporate driven research versus government slash education driven research is a big difference. Isn’t it?
Farron Cousins: Well, and, and these big pharmaceutical companies go out there, they headhunt these individuals, the, the smart folks, the scientists, and they say, hey, listen, you’ve got a very promising career ahead of you. How would you like to come make $300,000 a year, fresh outta school with your PhD? Uh, but instead of working on cancer, how about you work on this, you know, a new antacid for us.
Mike Papantonio: Yeah.
Farron Cousins: We, we, we know there’s a lot of heartburn medications, but you work on this one, we’ll pay you a lot of money, you’re gonna be fine.
Mike Papantonio: But, and the end result, we’re seeing more and more. It’s kinda like the chickens have come home to roost. Okay. And the end result is we’re seeing a disaster where it comes to performance of drug after drug, medical device after medical device. And it needs to be rethought. Farron, thanks for joining me. Okay.
Farron Cousins: Thank you.
Mike Papantonio: That’s for this week. But all these segments are gonna be available this coming week, right here on this channel. And you can follow us on Twitter, you can follow us @AmericasLawyer. I’m Mike Papantonio and this has been America’s Lawyer where every week we try to tell you the stories that corporate media won’t tell you because their advertisers won’t allow for it and sometimes their political connections won’t allow for it. So we try to avoid all that. We call balls and strikes here. There is no side. There is no Democrat side. There’s no Republican side. It is balls and strikes. It’s not for everybody, but we hope you enjoy it. We’ll see you next time.
